The three Sopharma AD factories - the one in Kazanlak, the Tablet production and Ampoule production in Sofia - have Nivalin in common, one of the strongest Sopharma products. Nivalin is sold in more than 10 countries outside Bulgaria, making it one of the most famous Sopharma products. It increases the intensity of the reflex centers of the spinal cord, medulla oblongata and cerebral cortex, thus influences all links of the reflex arc.
Sofia, Bulgaria, February 20, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for January 2025 the Company recorded an increase in sales of 7% compared to the same month of the previous year, incl. 6% increase in domestic sales and 8% increase in export sales.
Sofia, Bulgaria, January 31, 2025 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD (SFA: “Bulgarian Stock Exchange AD, SPH: Warsaw Stock Exchange) notifies that today the Company received a notification for significant shareholding from CUPF Alianz Bulgaria.
